Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

U.S. administers nearly 330 million doses of COVID-19 vaccines - CDC

Published 07/03/2021, 02:11 PM
Updated 07/03/2021, 02:15 PM
© Reuters. FILE PHOTO: A woman receives a COVID-19 vaccine at a clinic in Philadelphia, Pennsylvania, U.S., May 18, 2021. REUTERS/Hannah Beier/File Photo

The United States has administered 329,970,551 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 383,067,560 doses, the U.S. Centers for Disease Control and Prevention said on Saturday.

Those figures are up from the 328,809,470 vaccine doses the CDC said had gone into arms by July 2 out of 382,636,520 doses delivered.

The agency said 182,109,860 people had received at least one dose while 156,982,549 people are fully vaccinated as of Saturday.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine as of 6:00 a.m. ET on Saturday.

Latest comments

only important number is the 156,982,549 fully vaccinated.
Pray for them.
182 million Americans with compromised immune systems now.
Problem: huge spike in vacksine-related illnesses and deaths. Solution: Call it Delta Variant and blame the unvacksed.
correction only immune compromised if taken the two dose synthetic vaccine. The J&J vaccine doesn't destroy natural immune cells just enhances their effectiveness.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.